Evidence map›Paper›PMID 26075508›Full record

ArticleViruses2015

IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells.

William J Melvin, Temet M McMichael, Nicholas M Chesarino, Jocelyn C Hach, Jacob S Yount

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. ProteinOpen biology · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antiviral Protection by IFITM3 In Vivo.Current clinical microbiology reports · 2018
    Article
  13. IFITM3 Restricts Human Metapneumovirus Infection.The Journal of infectious diseases · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

William J MelvinDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, the Ohio State University, Columbus, OH 43210, USA. wjamesmelvin@gmail.com.
Temet M McMichaelDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, the Ohio State University, Columbus, OH 43210, USA. temet.mcmichael@osumc.edu.
Nicholas M ChesarinoDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, the Ohio State University, Columbus, OH 43210, USA. chesarino.1@osu.edu.
Jocelyn C HachDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, the Ohio State University, Columbus, OH 43210, USA. jocelyn.hach@gmail.com.
Jacob S YountDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, the Ohio State University, Columbus, OH 43210, USA. yount.37@osu.edu.
Interface (United States) · USThe Ohio State University · US

Funding

Integrative Training in Biomedical SystemsT32GM068412 · NIGMS · OHIO STATE UNIVERSITY · PI PARVIN, JEFFREY D · 2005 to 2020
$2.4M
Mechanistic analysis of a posttranslationally modified innate antiviral effectorR00AI095348 · NIAID · OHIO STATE UNIVERSITY · PI YOUNT, JACOB · 2013 to 2014
$494k
Molecular Control of IFITM3 in Restricting Influenza Virus InfectionR56AI114826 · NIAID · OHIO STATE UNIVERSITY · PI YOUNT, JACOB · 2015 to 2015
$366k
NIAID NIH HHS R00 AI095348NIAID NIH HHS R00AI095348NIAID NIH HHS R56 AI114826NIAID NIH HHS R56AI114826NIGMS NIH HHS T32 GM068412NIGMS NIH HHS T32GM068412
6 · The paper itself

Abstract

Interferon induced transmembrane proteins (IFITMs) found in vertebrates restrict infections by specific viruses. IFITM3 is known to be essential for restriction of influenza virus infections in both mice and humans. Vertebrate IFITMs are hypothesized to have derived from a horizontal gene transfer from bacteria to a primitive unicellular eukaryote. Since bacterial IFITMs share minimal amino acid identity with human IFITM3, we hypothesized that examination of bacterial IFITMs in human cells would provide insight into the essential characteristics necessary for antiviral activity of IFITMs. We examined IFITMs from Mycobacterium avium and Mycobacterium abscessus for potential antiviral activity. Both of these IFITMs conferred a moderate level of resistance to influenza virus in human cells, identifying them as functional homologues of IFITM3. Analysis of sequence elements shared by bacterial IFITMs and IFITM3 identified two hydrophobic domains, putative S-palmitoylation sites, and conserved phenylalanine residues associated with IFITM3 interactions, which are all necessary for IFITM3 antiviral activity. We observed that, like IFITM3, bacterial IFITMs were S-palmitoylated, albeit to a lesser degree. We also demonstrated the ability of a bacterial IFITM to co-immunoprecipitate with IFITM3 suggesting formation of a complex, and also visualized strong co-localization of bacterial IFITMs with IFITM3. However, the mycobacterial IFITMs lack the endocytic-targeting motif conserved in vertebrate IFITM3. As such, these bacterial proteins, when expressed alone, had diminished colocalization with cathepsin B-positive endolysosomal compartments that are the primary site of IFITM3-dependent influenza virus restriction. Though the precise evolutionary origin of vertebrate IFITMs is not known, our results support a model whereby transfer of a bacterial IFITM gene to eukaryotic cells may have provided a selective advantage against viral infection that was refined through the course of vertebrate evolution to include more robust signals for S-palmitoylation and localization to sites of endocytic virus trafficking.

Indexed as

Gene ExpressionAntiviral AgentsBacterial ProteinsCell LineConserved SequenceEndosomesEpithelial CellsHumansInterferon InducersLipoylationMycobacteriumOrthomyxoviridaeProtein Processing, Post-TranslationalProtein TransportRecombinant ProteinsSequence Homology, Amino AcidAntiviral AgentsBacterial ProteinsInterferon InducersRecombinant ProteinsIFITM3influenza virusinterferon induced transmembrane proteinpalmitoylationvirus restriction

Identifiers

PMID26075508
PMCPMC4488726
OpenAlexW2152411215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.